Endogenous Chemerin Limits the Severity of Ozone-Induced Airway Hyperresponsiveness Irrespective of Body Mass
Public Domain
-
2024/02/01
-
Details
-
Personal Author:
-
Description:Rationale: Tumor necrosis factor-a, a pleiotropic adipocytokine, limits the severity of airway hyperresponsiveness (AHR), a cardinal feature of asthma, in obese mice exposed to ozone (O3), a criteria pollutant and non-atopic asthma stimulus. However, in this phenomenon, the contribution of chemerin, an adipocytokine and non-chemokine chemoattractant for natural killer cells, macrophages and plasmacytoid dendritic cells, is unknown. Consequently, our goal was to asseverate the relevance of chemerin in the development of O3-induced AHR in obesity. Methods: Wild-type C57BL/6J mice and mice genetically deficient in chemerin (chemerin-deficient mice) were fed standard chow or a diet consisting of 60 kcal % fat (high-fat diet; HFD) from weaning until 30 weeks of age. At 30 weeks of age, mice were exposed to either filtered room air (air) or O3 (2 ppm) for three hours. Twenty-four hours following cessation of exposure, indices of airway responsiveness to methacholine [airway resistance and coefficients of lung tissue damping and elastance] were measured using the forced oscillation technique. Results: Consumption of a HFD by wild-type and chemerin-deficient mice led to obesity. Following air exposure, airway responsiveness to methacholine was greater in chemerin-deficient as compared to wild-type mice irrespective of the diet consumed. All mice exposed to O3 exhibited AHR. Nevertheless, regardless of the diet consumed, airway responsiveness was greater in chemerin-deficient as compared to wild-type mice following O3 exposure. Conclusions: Chemerin limits the severity of airway responsiveness in the presence and absence of inciting stimuli and may be a therapeutic target to limit exaggerated airway narrowing observed in obese and non-obese asthmatics. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0091-6749
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Volume:153
-
Issue:2
-
NIOSHTIC Number:nn:20070243
-
Citation:J Allergy Clin Immunol 2024 Feb; 153(2)(Suppl):AB256
-
CAS Registry Number:
-
Federal Fiscal Year:2024
-
Peer Reviewed:False
-
Source Full Name:Journal of Allergy and Clinical Immunology
-
Supplement:Suppl
-
Collection(s):
-
Main Document Checksum:urn:sha-512:1f52101187504f6fbbd0cf13032a8987c2b40dbf92daa2d3b1140a4077ed152db6533239b957cbd2da3ce0a88b35443b9e660235c0f6068e503caeb03bcbdf37
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like